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Prognostic Significance of Early Short-Term
Measurements of Heart Rate Variability Following
Acute Myocardial Infarction
Richard Steeds, MD, Janine Fletcher, PhD, Michael Smith, PhD, John West, MD,
Kevin Channer, MD, and John Townend, MD
This study of 164 subjects demonstrates that short-
term (5-minute) recordings of heart rate variability,
performed within 48 hours of admission, identify
those who survive acute myocardial infarction but
have an adverse prognosis. 2004 by Excerpta
Medica, Inc.
(Am J Cardiol 2004;94:1275–1278)
Cardiac autonomic control is profoundly derangedafter acute myocardial infarction (AMI), with ev-
idence of impaired vagal control and high levels of
sympathetic activity. The extent of this derangement,
in particular subnormal vagal activity, can be assessed
by the measurement of baroreflex sensitivity and heart
rate variability (HRV). There is considerable evidence
to show that low levels of these markers of cardiac
autonomic control are strongly and independently as-
sociated with an adverse prognosis.1 It is currently
widely believed that abnormal cardiac autonomic con-
trol after AMI is not merely a consequence of the
infarct but actively and deleteriously influences the
clinical course of the disease. The predictive value of
HRV has been exclusively derived from a 24-hour
Holter electrocardiogram, which is slow and expen-
sive to record and analyze.2 Isolated short-term (5-
minute) recordings may be of use, but data for their
predictive value are scarce and have been derived
largely through the post hoc selection of suitable frag-
ments of 24-hour recordings.3 The aim of this study
was to determine the prognostic significance of short-
term recordings of HRV soon after AMI.
• • •
Subjects were recruited from among patients ad-
mitted to coronary care units at 3 hospitals in the
United Kingdom between 1998 and 2000. This was a
substudy of a double-blind, placebo-controlled com-
parison of the effect of early (48 hours) and late (at
5 days) angiotensin-converting enzyme (ACE) inhibi-
tion with ramipril on short-term HRV. Data presented
in this report are derived from HRV recordings taken
before the study drug was administered. Patients were
eligible if they presented 48 hours of AMI in sinus
rhythm. AMI was diagnosed according to criteria of
the World Health Organization.4 Patients were ex-
cluded if they had established autonomic dysfunction,
had a noncardiac disease likely to influence mortality
rate, had a permanent pacemaker, were already treated
with ACE inhibitors, or treatment with ACE inhibitors
was contraindicated. Patients who were being treated
with -adrenoceptor antagonists before admission
were eligible for inclusion provided that there was no
change to drug dose after admission but before HRV
was examined. No patients began taking -adrenocep-
tor antagonists after admission but before HRV could
be examined. All patients were discharged on an ACE
inhibitor. All patients gave their written informed con-
sent before entry into the ramipril study, which was
approved by the local clinical research ethics commit-
tees. The substudy, which did not involve further
patient contact, received separate approval.
Studies were performed 48 hours of admission,
with subjects in the semi-supine position after a
2-hour fast and 30 minutes of rest in bed. Studies
were performed on the admitting ward at the bedside.
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Blood pressure was measured with automated oscil-
lometric sphygmomanometers after this rest period.
HRV was examined according to previously published
methods.5 Subjects were studied during free respira-
tion, and recordings of256 consecutive RR intervals
were made on each occasion. A respiratory signal was
obtained, displayed, and recorded from 2 electrodes
attached to the chest wall to monitor changes in im-
pedance with respiration.
HRV analysis was performed according to previ-
ously published methods.5 Standard time-domain
measures were calculated, including mean NN inter-
val, SD of NN-interval values (an index that expresses
overall variability), percent successive NN-interval
differences 50 ms, and root-mean-square of succes-
sive NN-interval differences. Percent successive NN-
interval differences 50 ms and root-mean-square of
successive NN-interval differences are measures of
high-frequency (“beat-to-beat”) variation mediated
principally by the vagus nerve.6 Frequency-domain
analysis was performed on stationary RR-interval se-
ries by using autoregressive modeling, as previously
described.5 Stationarity of the time series was tested
by calculation of the mean and variance of the first and
last 128 beats of each recording period to verify a
difference of 10% in the values for each time series.
The mean was subtracted from each point in the
RR-interval series, and power spectral analysis was
performed with Burg’s algorithm. The power of each
underlying frequency was quantified by decomposing
the total variability signal with the method of Zetter-
burg, thus enabling determination of spectral powers
at low frequency (centered at 0.1 Hz) and at high
frequency (corresponding to the observed respiratory
frequency) expressed in absolute and normalized units
([power/total power 0.04 Hz]  100%).
All patients were flagged at entry through the Na-
tional Health Service Central Registry, and notifica-
tion was received of date and cause of death. Com-
plete follow-up data were available for the cohort.
Baseline demographic and clinical characteristics
were compared with unpaired t test and Fisher’s exact
test. Variables of markedly non-normal distribution
(e.g., peak creatinine kinase) were appropriately trans-
formed before analysis. The association of the se-
lected HRV measurements and other variables with
prognosis was assessed with univariate and multivar-
iate Cox’s regression analyses. Survival curves were
constructed by the Kaplan-Meier method. A 2-tailed p
value 0.05 was considered statistically significant.
One hundred sixty-four subjects were recruited
from among patients admitted to the coronary care
units at 3 hospitals in the United Kingdom from 1998
to 2000. HRV analysis could not be performed in 27
patients after recruitment because of an excess ectopic
count or poor-quality electrocardiographic data in the
samples collected. Subjects in whom HRV analysis
could not be performed were less likely to smoke (19
[70%] vs 68 [50%] nonsmokers, p  0.05) and had
higher peak levels of creatine kinase (2,591  420 vs
1,821  119 U/L, p  0.02), but there were no other
differences from the group in whom HRV was ana-
lyzed. Over a median follow-up of 32 months (range
25 to 50), 21 subjects (13%) died of cardiovascular
disease, and 2 subjects were in the group whose HRV
analysis could not be performed. Therefore, HRV data
were available for 137 subjects, 19 of whom had died
by the census date.
Baseline demographic characteristics are presented
according to follow-up status in Table 1. Subjects who
died were older, had a higher rate of hypertension, a
lower body mass index, and lower left ventricular
ejection fraction than did those who survived. Clinical
characteristics of the index event are presented in
Table 2. Most subjects presented with cardiac disease
for the first time and received thrombolysis for acute
infarction (87%). Most of those recruited into the
TABLE 2 Clinical Characteristics of the Index Acute
Myocardial Infarction
Survivors Deceased
(n  143) (n  21) p Value
Previous cardiac event 26 (18%) 2 (10%) 0.33
Anterior wall AMI 75 (51%) 7 (33%) 0.16
Log10 (peak
creatine kinase)
3.14  0.38 3.20  0.37 0.45
Left ventricular
ejection fraction (%)
52  14 38  15 0.001
Thrombolyzed 125 (87%) 17 (81%) 0.49
Values are mean  SD or numbers (percentages).








Mean NN interval (ms) 722 836 975
SDNN (ms) 14.2 22.2 30.7
rMMSD (ms) 8.3 16.0 25.9
pNN50 0.0 3.9 35.3
Low frequency (ms2) 13.9 42.7 142.3
Low frequency (nu %) 21.9 36.0 53.8
High Frequency (ms2) 21.2 69.3 219.8




Total power (ms2) 203 491 875
nu  normalized units; pNN50  percent successive NN-interval differ-
ences 50 ms; rMMSD  root-mean-square of successive NN-interval differ-
ences; SDNN  SD of NN-interval values.
TABLE 1 Baseline Demographic Characteristics
Survivors Deceased
Variable (n  143) (n  21) p Value
Age (yrs) 62  11 69  11 0.008
Men 103 (72%) 11 (52%) 0.08
Smoker 67 (47%) 10 (48%) 0.99
Diabetes mellitus 13 (9%) 0 (0%) 0.15
Systemic hypertension 43 (30%) 12 (57%) 0.01
Total cholesterol (mmol/L) 5.8  1.1 5.8  1.3 0.94
Body mass index (kg/m2) 27  4 24  3 0.02
Positive family history 37 (28%) 5 (26%) 0.99
Values are mean  SD or numbers (percentages).
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study received aspirin (155 subjects; 95%) and all
received ACE inhibitors (164 subjects; 100%) before
discharge from the hospital. Prognosis was not signif-
icantly associated with early or late commencement of
ACE inhibition with ramipril (p  0.28). Among the
group as a whole, there was a low rate of prescription
at discharge of statins (92 subjects; 56%), -adreno-
ceptor antagonists (56 subjects; 34%), nitrates (10
subjects; 6%), and calcium antagonists (13 subjects;
8%). There was no difference between those subjects
who survived and those who died in terms of the
medication received at the time of discharge from the
hospital after AMI. Information on changes in drug
therapy after discharge was not available. Echocardi-
ography was not performed routinely in this study, but
data were collected from studies performed during the
in-patient stay at the request of the clinician respon-
sible for care. Assessment of left ventricular systolic
function was made in only 99 subjects (60%). There
was no association between survival rate and perfor-
mance/nonperformance of an echocardiogram (p 
0.53).
Measurements of assessed heart rate and HRV were
divided into quartiles, and survival of those in the lowest
quartile was compared with survival of those in the
higher quartiles. The distribution of HRV analyses is
presented in Table 3. The results of univariate Cox’s
regression analysis that compared survival rate, HRV,
and baseline variables are presented in Table 4. Mean
NN interval, SD of NN-interval values, and total power
showed long-term prognostic significance soon after
AMI. When assessed in multivariate models, mean NN
interval continued to be of prognostic significance (p
0.05). SD of NN-interval values carried independent
prognostic significance in the presence of all other vari-
ables with the exception of left ventricular ejection frac-
tion. Total power was not included in the multivariate
model because of the high correlation with SD of NN-
interval values (r  0.93).
• • •
This study provides evidence that decreases in time-
domain (mean NN interval and SD of NN-interval val-
ues) and frequency-domain (total power) indexes of
HRV assessed by short-term record-
ings carry prognostic significance after
AMI. Decreased HRV was associated
with a threefold increase in risk of car-
diac death on univariate analysis. The
predictive value of HRV that had been
assessed using short-term recordings
was maintained despite performance
of HRV assessment at an early stage
after AMI.
Previous studies of the predictive
value of short-term recordings of
HRV have been largely restricted to
retrospective analysis of clean peri-
ods extracted from longer 24-hour
monitors. Malik and Camm7 com-
pared the predictive value of 1-hour
segments of 24-hour recordings with
that of a complete 24-hour recording
in 20 subjects who had serious cardiac events and 20
subjects who had no complication at 6 months. The
1-hour HRV recordings were capable of stratifying
subjects according to increased risk, but the level of
risk attributable changed according to the time of the
hour taken for each patient. Bigger et al8 reported that
spectral HRV from recording periods lasting from 2 to
15 minutes randomly selected from 24-hour Holter
electrocardiograms predicted mortality rate after AMI.
In these 2 studies, the predictive power of the shorter
recordings was lower than that of the longer record-
ings. This finding was repeated by Fei et al3 who
compared the predictive value of SD of NN-interval
values taken from 5-minute segments with that of the
HRV index taken from the same 24-hour recordings.
Two other recent small studies have examined the
prognostic utility of short-term HRV assessment after
AMI. Vaage-Nilsen et al9 found that the SD of NN-
interval values 30 ms from a 5-minute period of
HRV assessment selected from a 48-hour Holter mon-
itor recorded 1 week after AMI, age 60 years, and
Holter evidence of ongoing myocardial ischemia were
independent predictors of mortality rate in a group of
54 subjects followed for 9 years. In a study by
Kautzner et al10 of 48 survivors of acute AMI, the SD
of NN-interval values measured during a 30-minute
recording 5 days after AMI was lower in 5 patients
who died than in the remaining survivors at 1 year.
Our findings are consistent with results from these
studies in demonstrating the prognostic utility of
short-term HRV assessment after AMI. The univariate
relative risk identified in our study for low-quartile mean
NN interval, SD of NN-interval values, and total power
is of lower magnitude than that found by others who
used full 24-hour recordings.1 Other studies that assessed
short-term recordings are consistent in demonstrating a
lower absolute level of risk compared with long-term
recordings, although independent prognostic significance
is maintained.3,7 Short-term recordings therefore remain
adequate as a screening tool to identify high-risk subjects
soon after infarction.
Short-term HRV assessment has several advan-
tages over assessment based on 24-hour Holter elec-
TABLE 4 Univariate Cox’s Regression Analysis Comparing Survival Rate, Heart
Rate Variability, and Baseline Variables.
Variable Relative Risk (95% CI) p Value
Age (yrs) 1.06/yr (1.01–1.010/yr) 0.008†
Women 0.45 (0.19–1.06) 0.07
Body mass index (kg/m2) 0.82/unit (0.69–0.98) 0.03*
Log10 (peak creatine kinase) 1.23 (0.73–2.07) 0.44
Anterior wall AMI 1.97 (0.79–4.9) 0.14
Left ventricular ejection fraction 35% 9.9 (3.4–28.4) 0.001†
Lowest quartile NN interval 3.8 (1.5–9.3) 0.004†
Lowest quartile SDNN 3.1 (1.2–7.5) 0.015*
Lowest quartile rMSSD 1.8 (0.6–4.9) 0.27
Lowest quartile low frequency (nu) 0.61 (0.18–2.14) 0.44
Lowest quartile high frequency (nu) 1.8 (0.7–4.9) 0.24
Lowest quartile total power 2.8 (1.1–7.3) 0.03*
*p 0.05.
†p 0.01.
95% CI  95% confidence interval; other abbreviations as in Table 3.
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trocardiographic monitoring. First, practical advan-
tages include the ability to study more patients over a
shorter duration. This decreases the significant amount
of complicated monitoring and analytic equipment
required to provide 24-hour Holter recordings in all
patients after AMI. Second, theoretical advantages
exist in providing “cleaner” short-term assessment of
HRV after AMI. HRV is mainly a reflection of the
influence of the autonomic nervous system on the
sinus node of the heart. Heart rate alters with many of
the changes in demand on the cardiovascular system
that are related to changes in respiration, posture, and
physical or mental activity. These changes are induced
by the control systems that coordinate the total pattern
of activity in the patient. Ideally, some information
should be available on this total pattern of activity
before HRV can be interpreted appropriately.11 How-
ever, total activity is likely to be highly variable across
patients studied over 24 hours at different times after
AMI (24-hour monitors have been applied from dis-
charge, from 5 days after admission, and 4 weeks
after discharge).1,2,8,12 Short-term recordings enable
studies to be performed under more controlled, static
conditions. This in turn should decrease the confound-
ing effects of other activities on comparisons of intra-
and interindividual results.13-16
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Echocardiographic Predictors of Prognosis After First
Acute Myocardial Infarction
Omar Obeidat, MD, Mohsin Alam, MD, George W. Divine, PhD, Fareed Khaja, MD,
Sidney Goldstein, MD, and Hani Sabbah, PhD
We prospectively studied 490 patients who had a first
myocardial infarction and performed a complete
2-dimensional echocardiographic study<48 hours of
admission. In addition to left ventricular ejection frac-
tion, multiple echocardiographic parameters of left
ventricular systolic and diastolic performances were
found to be independent predictors of 2-year mortal-
ity rate and congestive heart failure. 2004 by
Excerpta Medica, Inc.
(Am J Cardiol 2004;94:1278–1280)
Depressed left ventricular (LV) ejection fraction(EF) is associated with poor prognosis after acute
myocardial infarction (AMI),1,2 but hyperdynamic
noninfarcted segments may confound LVEF measure-
ment. Therefore, in the present study, we explored the
prognostic value of multiple echocardiographic pa-
rameters of LV systolic and diastolic performances
other than LVEF in patients who had a first AMI.
These parameters are the LV wall motion score index
(WMSI), diastolic and systolic sphericity indexes, de-
celeration time, and ischemic mitral regurgitation.
• • •
We prospectively studied 490 consecutive patients
who had been admitted to our coronary care unit with
first AMI from November 30, 1992 to December 17,
1996. AMI was diagnosed based on established elec-
trocardiographic and enzymatic criteria and on clinical
symptoms. Patients had to have ST-elevation AMI or
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